The Development of “Living Medicine” to Treat Drug-Resistant Lung Infections
Living Medicine is a new approach to treating lung infections that are resistant to traditional drugs. It involves using living organisms, such as bacteria or…
Pharmacy
Atezolizumab Approval for Advanced Alveolar Soft Part Sarcoma Follows Clinical Trial
Atezolizumab, a monoclonal antibody treatment, for advanced Alveolar Soft Part Sarcoma (ASPS), a rare type of cancer. This means that Atezolizumab can now be used…
New Drug Screening Technique Solutions Why Alzheimer’s Drugs Fail, New Targets Suggestions
Researchers led by the University of California San Diego created a new technique to test medications for the treatment of Alzheimer’s disease by examining disease…
A New Study Reveals Genes Can Predict Arthritis Treatment Response, Opening the Door to Future Drug Development
The effectiveness of particular pharmacological therapies for patients with rheumatoid arthritis (RA) can be strongly impacted by the molecular profiling of the diseased joint tissue,…
Promising MND Drug Slows Disease Progression and Has Physical Benefits for Patients
After a Phase 3 clinical trial revealed significant physical gains for patients after 12 months, researchers believe a new genetically tailored therapy for motor neurone…
‘Last Resort’ Antibiotic’s Common Drug-Resistant Superbug Develops Rapid Resistance
Colistin is a “last resort” antibiotic for patients with infections that have become multi-drug resistant. A study that was just released in Cell Reports describes…
A Limited Use of Current Cancer Therapy Demonstrates Significant Activity Against Other Cancers
Under specific circumstances, a medication that targets IDH1 mutations in some malignancies also seems to block the enzyme’s wild-type form. This characteristic explains why a…
Study Discovers That COVID-19 Rebound Following Paxlovid Use Is Likely the Result of Insufficient Drug Exposure
The most effective oral treatment for avoiding severe COVID-19 instances in high-risk persons is paxlovid. A health advisory on this alleged “COVID-19 rebound” was released…
In a Mouse Model, a New Personalized Treatment Idea to Prevent Colitis
According to a recent study, researchers at Georgia State University’s Institute for Biomedical Sciences have created a novel oral medication for ulcerative colitis that aims…
AI Examines Neuronal Changes to Determine whether Drugs Work for Patients with Neurodegenerative Disease
An artificial intelligence for assessing cell pictures that employs machine learning to anticipate the therapeutic effect of medications has been developed by a research team…
Differential Responses of Cancer Cells to Drug-Delivery Nanoparticles
Cancer treatments can be delivered to tumors in high dosages using nanoparticles while avoiding the negative side effects associated with chemotherapy. Only a small number…
A Cancer Drug that has been Shelved Could Receive a Second Chance with Personalized Medicine
Triplatin is effective against triple negative breast cancer, the most aggressive type of breast cancer with limited targeted medicines, according to a study by Virginia…
Load More